Quote from: gvmom on September 20, 2017, 10:52:18 AM
Will it be one of those cases where even if patients "win", we lose?
Yes. Of course. Naturally.
Quote from: LinksEtc on September 27, 2017, 07:04:13 AM
Obviously, I've collected a lot of negative examples in this thread ... mostly to encourage people to critically think about what is really in our (patients') best interest ... sometimes, if we don't look out for our needs, nobody else will ... we can get complacent if we blindly trust that others (docs, patient orgs, government, etc.) always have genuine concern for our well-being.
Yes, I'm feeling somewhat depressed and disheartened ...
at the same time, I still think that things have the potential to get better ...
whether talking about patients & healthcare ... or citizens and government ...
for instance, there are drugs that have been developed that save lives, there are docs who truly care, there are
patient orgs where patient needs are the primary focus, etc. ...
maybe we have to find that right balance between hope & critical thinking ...
-----------------------------------------------------------------
"Hope, Cynicism, and the Stories We Tell Ourselves"
By Maria Popova
https://www.brainpickings.org/2015/02/09/hope-cynicism/QuoteCritical thinking without hope is cynicism. Hope without critical thinking is naïveté.
Finding fault and feeling hopeless about improving the situation produces resignation — cynicism is both resignation's symptom and a futile self-protection mechanism against it.
QuoteDr Taylor received grant support for research from the National Institute of Food and Agriculture and from the Food Allergy Research and Resource Program consortium of over 90 food manufacturers and/or suppliers as well as royalties from Neogen Corp.
QuoteCSPI doesn't dispute the high quality of reports produced by the National Academies (which include the National Academy of Sciences, the Institute of Medicine, the National Academy of Engineering, and the National Research Council). But it says that the NAS should strengthen its policies for avoiding and disclosing conflicts of interest and for maintaining balance if the NAS is to maintain the credibility it currently enjoys.
QuoteInsufficient evidence exists on the prevalence and severity of allergies to other foods on the lists of priority allergenic foods in other countries, including molluscan shellfish, mustard, celery root, and buckwheat, to warrant their addition to the priority list in the United States.
Quotein the United States, some foods listed by the FDA as tree nuts (i.e., beech nut, butternut, chestnut, chinquapin, coconut, gingko nut, hickory nut, lichee nut, pili nut, shea nut) could be removed from the current priority list based on the paucity of data or low frequency of allergic reactions.
Quote"Health care's complicated [and] it's boring; I don't want to talk about it [and] the details are confusing," Kimmel said in his monologue. "And that's what these guys are relying on. ... They're taking care of the people who give them money, like insurance companies."
QuoteFood Allergy Research & Education (FARE) is the lead sponsor of this report
QuoteIn discussing the need for improved policies regarding labeling of packaged foods, the expert committee is recommending that the priority list of food allergens in the U.S. be periodically reviewed, noting that evidence of allergy prevalence and reaction severity to sesame may warrant inclusion on this list.
QuoteFARE and other groups nominated the members of the expert panel and the volunteer patient advisory panel.
QuoteFARE also assisted in securing diverse co-sponsors to provide funding support for the study.
Quotecommittee had the unique opportunity to hear directly from an advisory panel made up of nine parents of children with food allergies and one individual with food allergyhttps://www.nap.edu/read/23658/chapter/1 (Page x) .
QuoteWe're allowed to remind the researchers why they went into the job in the first place, but we're not supposed to be able to comment on methodology, even if the methodology is flawed because the researchers aren't aware of their own biases.
QuoteFor example, in the United States, some foods listed by the FDA as tree nuts (i.e., beech nut, butternut, chestnut, chinquapin, coconut, gingko nut, hickory nut, lichee nut, pili nut, shea nut) could be removed from the current priority list based on the paucity of data or low frequency of allergic reactions. In addition, evidence of the allergy prevalence and reaction severity to sesame seeds may warrant their inclusion on the priority allergen list in the United States.
QuoteThe Asthma and Allergy Foundation of America (AAFA) is standing up for people allergic to sesame. We joined with a consumer advocacy group to ask the Food and Drug Administration (FDA) to add sesame to the list of ingredients that must be disclosed on food labels.
QuoteWe urge the FDA to include sesame among the list of ingredients that must be disclosed
QuoteAs the leading advocacy organization representing the 15 million Americans with food allergies, FARE supports the addition of sesame to the list of "major food allergens" that are required to be identified on ingredient labels of processed foods.
Quote
Sesame is not currently included in the list of major allergens that must be declared by food manufacturers as part of the Food Allergen Labeling Consumer Protection Act (FALCPA), although FARE supports the addition of sesame to the list of "major food allergens" that are required to be identified on ingredient labels of processed foods.
QuoteThe list below includes information about ingredients to avoid if you have a sesame allergy, including uncommon names for the ingredient.
QuoteThere should be a point where you say, the way you would with a child, this isn't mine anymore.
QuoteAll comments submitted to any FDA docket on or after October 15, 2015, will be publically posted, unless otherwise determined not to be subject to posting as described in the SUPPLEMENTARY INFORMATION section.
QuoteSUMMARY: The Food and Drug Administration (FDA or Agency) is changing the Agency's long standing practice of not publically posting on http://www.regulations.gov comments submitted by individuals in their individual capacity. These are generally comments from people who self-identify as an ''individual consumer'' under the field titled ''Category (Required)'' on the ''Your Information'' page on http:// www.regulations.gov. Changing FDA's practice to routinely post these comments, as we do other comments, will increase the transparency and public utility of FDA's public dockets.
It will better enable our public dockets to function as intended: To share information and encourage an open exchange of ideas.
QuoteThis change fulfills a recommendation from the 2010 FDA Transparency Initiative
QuoteOn Wednesday, October 14, FARE was joined by Dr. Robert Wood, for a webinar titled Understanding and Managing Sesame Allergy.
QuoteMr. Riccio encouraged webinar attendees to share their sesame allergy stories with FARE, sign up for advocacy alerts, and let their congressmen/women know that adding sesame FALCPA is an issue important to their families.